3 February 2023
Spectral MD Holdings, Ltd.
("Spectral MD" or the "Company")
Total Voting Rights
LONDON, U.K. AND DALLAS, TX, U.S. - Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company with proprietary AI algorithms and optical technology for faster and more accurate treatment decisions in wound care, announces that, as at the date of this announcement, there are 136,201,515 ordinary shares of Common Stock of US $0.001 each ("Shares") in issue, with one voting right per Share. This follows the issue of 104,451 Shares in January in satisfaction of option exercises and in accordance with the Company's block listing, details of which were announced on 7 November 2022.
The total number of voting rights in the Company is therefore 136,201,515.
This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the issued share capital of the Company under the Company's Certificate of Incorporation. No Common Stock is held in treasury.
For further information please contact:
| Spectral MD Holdings, Ltd. | investors.spectralmd.com | ||
| Wensheng Fan, Chief Executive Officer | via Walbrook PR | ||
| Nils Windler, Chief Financial Officer |
| ||
|
|
| ||
| SP Angel Corporate Finance LLP (NOMAD and Joint Broker) | Tel: +44 (0)20 3470 0470 | ||
| Stuart Gledhill/Harry Davies-Ball (Corporate Finance) Vadim Alexandre/Rob Rees (Sales & Broking)
|
| ||
| Stifel Nicolaus Europe Limited (Joint Broker) Charles Hoare / Ben Maddison / Nick Harland Will Palmer-Brown | Tel: +44 (0)20 7710 7600 | ||
|
|
| ||
| Walbrook PR Ltd (Media & Investor Relations) | Tel: +44 (0)20 7933 8780 or spectralMD@walbrookpr.com | ||
| Paul McManus / Louis Ashe-Jepson / Sam Allen | Mob: +44 (0)7980 541 893 / +44 (0)7747 515 393 +44 (0)7502 558 258 | ||
About Spectral MD:
We are a dedicated team of forward-thinkers striving to revolutionize the management of wound care by "Seeing the Unknown" ® with our DeepView® Wound Imaging System.
www.spectralmd.com
info@spectralmd.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.